...
首页> 外文期刊>Physical chemistry chemical physics: PCCP >Polymer-assisted drug sequestration from plasma protein by a surfactant with curtailed denaturing capacity
【24h】

Polymer-assisted drug sequestration from plasma protein by a surfactant with curtailed denaturing capacity

机译:用缩小的变性能力通过表面活性剂从血浆蛋白螯合的聚合物辅助药物螯合

获取原文
获取原文并翻译 | 示例

摘要

The capability of a surfactant to sequester a drug bound to plasma protein was investigated using steady-state and time-resolved spectroscopic techniques. Surfactants are known to denature protein, and hence are not suitable for the sequestration of a drug from protein. Herein, we show that the denaturing capacity of a surfactant is curtailed completely and its drug sequestration power is enhanced in the presence of biocompatible Pluronic micelles due to the formation of unique supramolecular assemblies. Further, our detailed studies indicate that the concentration of surfactant required for the sequestration of a drug is less than its critical micellar concentration (CMC). The extent of sequestration of drug by polymer-surfactant supramolecular assemblies can be tuned finely by controlling the concentration of surfactant. Detailed analysis showed that up to similar to 85% sequestration of a drug from plasma protein could be achieved using a sub-CMC concentration of surfactant. Our results clearly show that controlled sequestration of a drug from plasma protein can be achieved with a reduction in the protein denaturing properties of surfactants.
机译:使用稳态和时间分辨的光谱技术研究了表面活性剂螯合与血浆蛋白结合的药物的能力。已知表面活性剂可使蛋白质,因此不适合于来自蛋白质的药物的螯合。在此,我们表明,由于独特的超分子组件的形成,完全缩减了表面活性剂的变性能力并在生物相容的Pluronic胶束存在下提高了其药物螯合力。此外,我们的详细研究表明,药物封存所需的表面活性剂浓度小于其临界胶束浓度(CMC)。通过聚合物 - 表面活性剂超分子组件通过控制表面活性剂的浓度来调谐药物的封存程度。详细分析表明,通过表面活性剂的亚CMC浓度,可以实现与血浆蛋白的药物依赖于85%的85%封存。我们的结果清楚地表明,通过降低表面活性剂的蛋白质变性性能,可以实现来自血浆蛋白的药物的控制螯合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号